Sanofi to Acquire Blueprint Medicines for $9.1B Business By Jack Mulligan Sanofi SA (NASDAQ: SNY) announced on Monday that it has agreed to acquire Blueprint Medicines Corporation (NASDAQ: BPMC) in a…
